589 related articles for article (PubMed ID: 17207827)
1. Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone: Mass spectrometric identification of urinary metabolites.
Kohler M; Parr MK; Opfermann G; Thevis M; Schlörer N; Marner FJ; Schänzer W
Steroids; 2007 Mar; 72(3):278-86. PubMed ID: 17207827
[TBL] [Abstract][Full Text] [Related]
2. Metabolic studies of formestane in horses.
Leung GN; Kwok WH; Wan TS; Lam KK; Schiff PJ
Drug Test Anal; 2013 Jun; 5(6):412-9. PubMed ID: 23339113
[TBL] [Abstract][Full Text] [Related]
3. Metabolic studies of mesterolone in horses.
Ho EN; Leung DK; Leung GN; Wan TS; Wong HN; Xu X; Yeung JH
Anal Chim Acta; 2007 Jul; 596(1):149-55. PubMed ID: 17616252
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of androsta-1,4,6-triene-3,17-dione and detection by gas chromatography/mass spectrometry in doping control.
Parr MK; Fusshöller G; Schlörer N; Opfermann G; Piper T; Rodchenkov G; Schänzer W
Rapid Commun Mass Spectrom; 2009 Jan; 23(2):207-18. PubMed ID: 19089863
[TBL] [Abstract][Full Text] [Related]
5. 6alpha-Methylandrostenedione: gas chromatographic mass spectrometric detection in doping control.
Parr MK; Kazlauskas R; Schlörer N; Opfermann G; Piper T; Schulze G; Schänzer W
Rapid Commun Mass Spectrom; 2008; 22(3):321-9. PubMed ID: 18181236
[TBL] [Abstract][Full Text] [Related]
6. Urine stability and steroid profile: towards a screening index of urine sample degradation for anti-doping purpose.
Mazzarino M; Abate MG; Alocci R; Rossi F; Stinchelli R; Molaioni F; de la Torre X; Botrè F
Anal Chim Acta; 2011 Jan; 683(2):221-6. PubMed ID: 21167974
[TBL] [Abstract][Full Text] [Related]
7. Involvement of multiple biotransformation processes in the metabolic elimination of testosterone by juvenile and adult fathead minnows (Pimephales promelas).
Parks LG; LeBlanc GA
Gen Comp Endocrinol; 1998 Oct; 112(1):69-79. PubMed ID: 9748405
[TBL] [Abstract][Full Text] [Related]
8. Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: endogenous steroids urinary profile after multiple oral doses.
Mazzarino M; Braganò MC; de la Torre X; Molaioni F; Botrè F
Steroids; 2011 Nov; 76(12):1400-6. PubMed ID: 21745489
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry of steroid glucuronide conjugates. II-Electron impact fragmentation of 3-keto-4-en- and 3-keto-5alpha-steroid-17-O-beta glucuronides and 5alpha-steroid-3alpha,17beta-diol 3- and 17-glucuronides.
Thevis M; Opfermann G; Schmickler H; Schänzer W
J Mass Spectrom; 2001 Sep; 36(9):998-1012. PubMed ID: 11599078
[TBL] [Abstract][Full Text] [Related]
10. Urinary analysis of 16(5alpha)-androsten-3alpha-ol by gas chromatography/combustion/isotope ratio mass spectrometry: implications in anti-doping analysis.
Saudan C; Baume N; Mangin P; Saugy M
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(1):157-64. PubMed ID: 15358320
[TBL] [Abstract][Full Text] [Related]
11. Seized designer supplement named "1-Androsterone": identification as 3β-hydroxy-5α-androst-1-en-17-one and its urinary elimination.
Parr MK; Opfermann G; Geyer H; Westphal F; Sönnichsen FD; Zapp J; Kwiatkowska D; Schänzer W
Steroids; 2011 May; 76(6):540-7. PubMed ID: 21310167
[TBL] [Abstract][Full Text] [Related]
12. Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite.
Thevis M; Geyer H; Mareck U; Flenker U; Schänzer W
Ther Drug Monit; 2007 Apr; 29(2):236-47. PubMed ID: 17417080
[TBL] [Abstract][Full Text] [Related]
13. Influences of musk administration on the doping test.
He Y; Wang J; Liu X; Xu Y; He Z
Steroids; 2013 Nov; 78(11):1047-52. PubMed ID: 23891647
[TBL] [Abstract][Full Text] [Related]
14. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine.
Sobolevsky T; Rodchenkov G
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):121-7. PubMed ID: 22142641
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the steroid profile in doping control analysis.
Mareck U; Geyer H; Opfermann G; Thevis M; Schänzer W
J Mass Spectrom; 2008 Jul; 43(7):877-91. PubMed ID: 18570179
[TBL] [Abstract][Full Text] [Related]
16. Alternative long-term markers for the detection of methyltestosterone misuse.
Gómez C; Pozo OJ; Marcos J; Segura J; Ventura R
Steroids; 2013 Jan; 78(1):44-52. PubMed ID: 23127819
[TBL] [Abstract][Full Text] [Related]
17. In vitro metabolism of [4-14C] androstenedione and [4-14C] testosterone by rabbit placenta.
Marchut M
Endocrinol Exp; 1977; 11(2):139-46. PubMed ID: 301822
[TBL] [Abstract][Full Text] [Related]
18. Profiling of urinary steroids by gas chromatography-mass spectrometry detection and confirmation of androstenedione administration using isotope ratio mass spectrometry.
Wang J; Wu M; Liu X; Xu Y
Steroids; 2011 Dec; 76(14):1560-5. PubMed ID: 21945895
[TBL] [Abstract][Full Text] [Related]
19. Combination of carbon isotope ratio with hydrogen isotope ratio determinations in sports drug testing.
Piper T; Emery C; Thomas A; Saugy M; Thevis M
Anal Bioanal Chem; 2013 Jun; 405(16):5455-66. PubMed ID: 23568614
[TBL] [Abstract][Full Text] [Related]
20. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
